A Pilot Study to Determine the Bioavailability of Oral Beta-Aminoisobutyric Acid (BAIBA) Ingestion

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

February 1, 2022

Conditions
Absorption; Chemicals
Interventions
DIETARY_SUPPLEMENT

Beta-Aminoisobutyric Acid

All supplements provided to all research participants containing BAIBA, L-Valine or placebo will be procured and prepared in a similar manner. Briefly, beta-amino isobutyric acid (BAIBA), L-Valine (an amino acid), and a resistant starch commonly consumed in various foods will be used as test agents for this study protcol. All supplements (both BAIBA and Valine) as well as placebo are produced and provided by NNB Nutrition. A certificate of analysis is provided in the attachments for the BAIBA. All supplements (BAIBA, L-Valine, and placebo) will be administered in gelatin capsules and consumed with a specified amount of cold tap water. The same number of capsules will be administered each time. All doses will be capsulated by manufacturer prior to use in the study protocol.

Trial Locations (1)

63301

Lindenwood University, Saint Charles

All Listed Sponsors
collaborator

NNB Nutrition

UNKNOWN

lead

Lindenwood University

OTHER

NCT05328271 - A Pilot Study to Determine the Bioavailability of Oral Beta-Aminoisobutyric Acid (BAIBA) Ingestion | Biotech Hunter | Biotech Hunter